No Data
Evercore ISI Starts BioNTech With In Line Rating, $100 Price Target
BioNTech (BNTX) has an average rating of outperform and price targets ranging from $89.46 to $171.30, according to analysts polled by Capital IQ. Price: 92.49, Change: -0.23, Percent Change: -0.25
BioNTech Initiated at In-Line by Evercore ISI Group
BioNTech Initiated at In-Line by Evercore ISI Group
BioNTech Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/14/2024 8.7% Evercore ISI Group → $100 Initiates Coverage On → In-Line 05/08/2024 22.83% HC Wainwright
Express News | BioNTech SE : Evercore ISI Initiates Coverage With in Line Rating; Price Target $100
We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
Novavax Hits a 52-week High as Sanofi Deal Prompts J.P. Morgan Upgrade